Leukemia
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients 18 or older, able to state his/her wishes and has (or is suspected to have) a hematological disease.
Exclusion criteria
Exclusion criteria: If diagnosis demonstrates that the patient does not have any of the hematological diseases, as mentioned under the inclusion citeria, he/she is excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This project intends to gain knowledge on the properties (such as DNA features) of the stored tissue or cells. These data are combined with clinical data of the disease, sensitivity to treatment and possibly with important environmental factors and patient data (i.e. age, previous diseases). From these analyses knowledge can be gained about: - the nature and possibly the origin of the disease - reasons why the disease responds well or poorly to the applied treatment - the treatment outcome. | — |
Secondary
| Measure | Time frame |
|---|---|
| A 'minimal dataset' describing the collected clinical data/variables, has been drafted for every hematological disease in agreement with all eight UMC's (see attachment 1 'Minimal dataset' of the 'Reglement Parel Leukemie, Myeloom, Lymfoom en Myelofibrosis, which is added to the Protocol Biobank 'Leukemie, Myeloom, Lymfklierkanker'). | — |
Countries
Netherlands
Outcome results
None listed